文献速递物质与行为成瘾儿童青少年精神

哌甲酯诱导腹侧纹状体多巴胺增加的性别差异

Sex differences in methylphenidate-induced dopamine increases in ventral striatum.
PubMed 文献 · Mol Psychiatry · 2021-10-27

本研究分析两项独立[11C]雷氯必利PET影像研究,共95人(男65、女30),在盲法安慰剂对照设计中测量口服60 mg或静脉0.5 mg/kg哌甲酯诱导的纹状体多巴胺增加。女性报告更强的「药物效应」感受,且腹侧纹状体多巴胺释放显著大于男性,而背侧纹状体多巴胺增加及血浆哌甲酯水平无显著性别差异。

要点

  • 女性对哌甲酯的腹侧纹状体多巴胺释放显著大于男性。
  • 女性报告更强的「药物效应」主观感受。
  • 背侧纹状体多巴胺增加及血浆哌甲酯水平无显著性别差异。

核心结论

  • 女性在腹侧纹状体而非背侧纹状体对哌甲酯诱导的多巴胺增加更敏感,提示多巴胺奖赏系统敏感性存在性别差异,可能与物质使用障碍和ADHD易感性性别差异有关。

研究设计与样本

  • 分析两项独立[11C]雷氯必利PET脑影像研究,采用盲法安慰剂对照设计,测量哌甲酯诱导的纹状体多巴胺增加。
  • Cohort A为口服60 mg哌甲酯,Cohort B为静脉0.5 mg/kg哌甲酯,总样本n=95(男65、女30)。

主要发现

  • 女性相比男性报告更强的「药物效应」感受。
  • 女性在口服和静脉哌甲酯后腹侧纹状体(伏隔核所在区域)多巴胺释放均显著大于男性。
  • 口服或静脉给药后背侧纹状体多巴胺增加无显著性别差异,血浆哌甲酯水平也无差异。

临床怎么用

  • 解读哌甲酯疗效与不良反应时需考虑性别差异,尤其关注奖赏相关效应。
  • 女性可能对哌甲酯的奖赏系统效应更敏感,处方及随访可个体化评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sex differences in the prevalence of dopamine-related neuropsychiatric diseases and in the sensitivity to dopamine-boosting drugs such as stimulants is well recognized. Here we assessed whether there are sex differences in the brain dopamine system in humans that could contribute to these effects. We analyzed data from two independent [11C]raclopride PET brain imaging studies that measured methylphenidate-induced dopamine increases in the striatum using different routes of administration (Cohort A = oral 60 mg; Cohort B = intravenous 0.5 mg/kg; total n = 95; 65 male, 30 female), in blinded placebo-controlled designs. Females when compared to males reported stronger feeling of "drug effects" and showed significantly greater dopamine release in the ventral striatum (where nucleus accumbens is located) to both oral and intravenous methylphenidate. In contrast, there were no significant differences in methylphenidate-induced increases in dorsal striatum for either oral or intravenous administration nor were there differences in levels of methylphenidate in plasma. The greater dopamine increases with methylphenidate in ventral but not dorsal striatum in females compared to males suggests an enhanced sensitivity specific to the dopamine reward system that might underlie sex differences in the vulnerability to substance use disorders and to attention-deficit/hyperactivity disorder (ADHD).

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Manza P, Shokri-Kojori E, Wiers CE, et al. Sex differences in methylphenidate-induced dopamine increases in ventral striatum. Mol Psychiatry. 2021. PMID: 34707237. doi:10.1038/s41380-021-01294-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。